ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Clostridium difficile Recurrence in Abdominal Organ Transplant Recipients: Metronidazole versus Oral Vancomycin

A. Moorman,1 S. Todd,1 G. Lyon III,2 H. Triemer.1

1Department of Pharmaceutical Services, Emory University Hospital, Atlanta, GA
2Division of Infectious Diseases, Emory University, Atlanta, GA.

Meeting: 2018 American Transplant Congress

Abstract number: C336

Keywords: Bacterial infection, Kidney transplantation, Liver transplantation, Reinfection

Session Information

Session Name: Poster Session C: Transplant Infectious Diseases

Session Type: Poster Session

Date: Monday, June 4, 2018

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Clostridium difficile infection (CDI) is one of the most common hospital-acquired infections among the general inpatient population with recurrence rates of 20-30% despite appropriate treatment. Solid organ transplant recipients have a higher incidence of CDI due to their immunosuppressed state. This study aimed to determine if the antibiotic chosen for initial CDI treatment impacts recurrence rates in transplant recipients. In this retrospective analysis of 2281 adult abdominal organ transplant recipients, 163 (7.1%) had an initial CDI within one year of transplant. Twenty patients (15.9%) had recurrent CDI within 6 months of the initial CDI. There was no difference in the primary outcome of CDI recurrence in transplant recipients who received metronidazole or oral vancomycin (17.4% vs. 11.8%, p=0.5865) for treatment of the initial CDI. When CDI was assessed by transplanted organ, 22.6% of kidney transplant recipients receiving metronidazole versus 20% receiving oral vancomycin had CDI recurrence. CDI recurrence was found in 6.9% of liver transplant recipients receiving metronidazole versus in 5% receiving oral vancomycin. Initial CDI occurred within the first six months of transplant in 87% of patients. Recurrent CDI was experienced in 90% of patients within three months of the initial CDI. Based on this cohort of abdominal organ transplant recipients, the antibiotic selected for initial CDI treatment did not influence CDI recurrence rates, and antibiotic treatment selection should not differ from the general population.

CITATION INFORMATION: Moorman A., Todd S., Lyon III G., Triemer H. Clostridium difficile Recurrence in Abdominal Organ Transplant Recipients: Metronidazole versus Oral Vancomycin Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Moorman A, Todd S, III GLyon, Triemer H. Clostridium difficile Recurrence in Abdominal Organ Transplant Recipients: Metronidazole versus Oral Vancomycin [abstract]. https://atcmeetingabstracts.com/abstract/clostridium-difficile-recurrence-in-abdominal-organ-transplant-recipients-metronidazole-versus-oral-vancomycin/. Accessed May 31, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences